These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24777841)

  • 41. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes.
    Yanyali A; Aytug B; Horozoglu F; Nohutcu AF
    Am J Ophthalmol; 2007 Jul; 144(1):124-6. PubMed ID: 17601433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
    Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
    Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema.
    Byeon SH; Kwon YA; Oh HS; Kim M; Kwon OW
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):387-94. PubMed ID: 17803438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.
    Farese E; Cennamo G; Velotti N; Traversi C; Rinaldi M; De Crecchio G
    Eur J Ophthalmol; 2014; 24(5):761-70. PubMed ID: 24585424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherapy in DME.
    Berger A; Sheidow T; Cruess AF; Arbour JD; Courseau AS; de Takacsy F
    Can J Ophthalmol; 2015 Jun; 50(3):209-16. PubMed ID: 26040221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One Year.
    Mylonas G; Schranz M; Scholda C; Karst S; Reiter G; Baumann L; Schmidt-Erfurth U; Kriechbaum K
    Curr Eye Res; 2020 Sep; 45(9):1107-1113. PubMed ID: 31961224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
    Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
    Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Maggio E; Sartore M; Attanasio M; Maraone G; Guerriero M; Polito A; Pertile G
    Am J Ophthalmol; 2018 Nov; 195():209-222. PubMed ID: 30098350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
    Song JH; Lee JJ; Lee SJ
    Korean J Ophthalmol; 2011 Jun; 25(3):156-60. PubMed ID: 21655039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial.
    Entezari M; Flavarjani ZK; Ramezani A; Nikkhah H; Karimi S; Moghadam HF; Daftarian N; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2375-2380. PubMed ID: 31401683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional and anatomic response of the retina and the choroid to intravitreal bevacizumab for macular edema.
    Forte R; Cennamo G; Breve MA; Vecchio EC; de Crecchio G
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):69-75. PubMed ID: 22059904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Refractive changes after pharmacologic resolution of diabetic macular edema.
    Deák GG; Lammer J; Prager S; Mylonas G; Bolz M; Schmidt-Erfurth U;
    Ophthalmology; 2014 May; 121(5):1054-8. PubMed ID: 24439462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema.
    Hanhart J; Tiosano L; Averbukh E; Banin E; Hemo I; Chowers I;
    Eye (Lond); 2014 Jun; 28(6):646-53. PubMed ID: 24858528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of intravitreal bevacizumab (Avastin) for short-term treatment of diabetic macular edema.
    Nagasawa T; Naito T; Matsushita S; Sato H; Katome T; Shiota H
    J Med Invest; 2009 Aug; 56(3-4):111-5. PubMed ID: 19763022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema.
    Güler E; Totan Y; Betül Güragaç F
    Cutan Ocul Toxicol; 2017 Jun; 36(2):180-184. PubMed ID: 28366074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal bevacizumab treatment for refractory diabetic macular edema.
    Yuksel E; Ozdek S; Yuksel N; Hasanreisoglu B
    Int Ophthalmol; 2013 Dec; 33(6):659-63. PubMed ID: 23508574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single intravitreal bevacizumab injection effects on contrast sensitivity in macular edema from branch retinal vein occlusion.
    Preti RC; Ramirez LM; Pimentel SL; Motta AA; Machado CG; Monteiro ML; Takahashi WY
    Arq Bras Oftalmol; 2012; 75(1):29-32. PubMed ID: 22552414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema.
    Nepomuceno AB; Takaki E; Paes de Almeida FP; Peroni R; Cardillo JA; Siqueira RC; Scott IU; Messias A; Jorge R
    Am J Ophthalmol; 2013 Sep; 156(3):502-510.e2. PubMed ID: 23795985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.